Crossmark

Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway

Crossref DOI link: https://doi.org/10.1038/s41419-018-0297-3

Published Online: 2018-02-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lv, Qi

Wang, Kai

Qiao, Simiao

Yang, Ling

Xin, Yirong

Dai, Yue

Wei, Zhifeng
License Information

Text and Data Mining valid from 2018-02-15

Version of Record valid from 2018-02-15
More Information

Article History

Received: 20 November 2017

Revised: 9 January 2018

Accepted: 9 January 2018

First Online: 15 February 2018

Competing interest

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below